Search research articles
Contact Us
Filters
Showing results (131-140 of 155) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 9, 2021
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin
Elisa Fontana, Jeff Meyers, Alberto Sobrero, et al.
Journal of the National Cancer Institute
|
February 4, 2016
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
David Tougeron, Guillaume Mouillet, Isabelle Trouilloud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2019
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations
Cindy Neuzillet, Andrea Casadei Gardini, Bertrand Brieau, et al.
Lancet (London, England)
|
August 2, 2025
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
Etienne Brain, Olivier Mir, Emmanuelle Bourbouloux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2025
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials
Claire Gallois, Marine Sroussi, Thierry André, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD study
Benoit Rousseau, Marc Hilmi, Antoine Falcoz, et al.
Clinical Colorectal Cancer
|
October 1, 2019
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan
Lorenzo Fornaro, Francesco Leone, Angélique Vienot, et al.
International Journal of Cancer
|
January 24, 2020
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study
David Tougeron, Benjamin Sueur, Aziz Zaanan, et al.
The New England Journal of Medicine
|
March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
BMC Cancer
|
July 29, 2023
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82)
Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 155) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 9, 2021
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin
Elisa Fontana, Jeff Meyers, Alberto Sobrero, et al.
Journal of the National Cancer Institute
|
February 4, 2016
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
David Tougeron, Guillaume Mouillet, Isabelle Trouilloud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2019
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations
Cindy Neuzillet, Andrea Casadei Gardini, Bertrand Brieau, et al.
Lancet (London, England)
|
August 2, 2025
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
Etienne Brain, Olivier Mir, Emmanuelle Bourbouloux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2025
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials
Claire Gallois, Marine Sroussi, Thierry André, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD study
Benoit Rousseau, Marc Hilmi, Antoine Falcoz, et al.
Clinical Colorectal Cancer
|
October 1, 2019
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan
Lorenzo Fornaro, Francesco Leone, Angélique Vienot, et al.
International Journal of Cancer
|
January 24, 2020
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study
David Tougeron, Benjamin Sueur, Aziz Zaanan, et al.
The New England Journal of Medicine
|
March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
BMC Cancer
|
July 29, 2023
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82)
Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto, et al.
Page
of 16